Prelude Therapeutics, Inc. (PRLD)
1.91
+0.10
(+5.52%)
USD |
NASDAQ |
Jan 20, 15:08
Prelude Therapeutics Profit Margin (Quarterly): -303.5% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Incyte Corp. | 31.05% |
| BioLife Solutions, Inc. | 2.21% |
| Protalix Biotherapeutics, Inc. | 13.19% |
| Aclaris Therapeutics, Inc. | -443.0% |
| Relay Therapeutics, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -106.4% |
| Return on Assets | -77.23% |
| Return on Invested Capital | -90.83% |
| Gross Profit Margin (Quarterly) | 93.46% |
| Operating Margin (Quarterly) | -314.1% |
| Return on Net Operating Assets | -322.1% |